CAR-T cell therapiesTocilizumabCRSuniversity hospitalmultiorgan failure
…ty hospital is involved as a sponsor of clinical trials on both CAR-T cell therapies and bispecific antibodies (BsAbs), actively contributing to the…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 601–660 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Non-operative Treatment Strategy2Multidisciplinary pain management2Insulin pump therapy2LDKT2DDKT2appendectomy2Pericardiocentesis2TVE2ChT2Cryoablation2Deprescribing2EndoFLIP2alternative treatment2COMBO2Procedural Sedation2csDMARDs2dCBT-I2CNA2FIT2McKenzie method2Medication reconciliation2Metabolic-bariatric surgery2PCA2POBA2CARTA2CRFA2HFNC2LT-NIV2SRS2Sharp debridement2head and neck radiotherapy2LLETZ2PRP2Respiratory physiotherapy2Respiratory rehabilitation2SRFA2nasal packing2prophylaxis2Cryoneurolysis2Fibrinolysis2Inhalers2T-FUS2AVT2Adenotonsillectomy2BT2Contrast enema2HMV2IFD2KRT2PR-buddy2Placenta-derived products2Vertebral augmentation2local consolidative therapy2neoadjuvant immunochemotherapy2neuraxial anaesthesia2rescue treatment2Autologous fat transfer2COT2Corticosteroid treatment2EMR2
Articles mentioning treatments
7,227 articles · page 390 of 603CAR-T cell therapyTocilizumabhaematologic malignanciesuniversity hospitalCRScorticosteroidscytokine release syndromemultiorgan failure
…strate the central role we play in this therapeutic innovation. CAR-T cell therapy is a major breakthrough in the management of haematologic malig…
ketogenic dietAicardi syndromevigabatrinperampanellevetiracetamhydrocortisonelamotriginefenfluraminevalproic acidtopiramate+2 more
…motrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocorti…
therapeutic anticoagulationaspirinVTEhaemorrhagecerebral accidents
…drug chart and administered at the correct time. With regard to therapeutic anticoagulation, statistical significance was found in the documentation of ind…
Oncology treatmentenzalutamideapalutamidepazopanibabirateroneolaparibsunitinibcapecitabineimatinibosimertinib+8 more
…Background and Importance Oncology treatment requires continuous monitoring and appropriate pharmacotherapeu…
Chimeric Antigen Receptor T-cell (CAR-T) therapyaxicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelmultiple myelomaDLBCLanakinraacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANS+1 more
…Background and Importance Chimeric Antigen Receptor T-cell (CAR-T) therapy has improved outcomes in relapsed or refractory haematological …
Combination therapylinezolidceftazidime-avibactamcolistinoxazolidinonesnosocomial infectionsurinary tract infectionsmultidrug-resistant infections
…inly for respiratory (21.9%) and urinary tract infections (8%). Combination therapy was used in 26.7% of prescriptions, mainly for synergistic purp…
Immune checkpoint inhibitorspembrolizumabtertiary hospitalNSCLCmetastatic non-small-cell lung adenocarcinomaproton pump inhibitors
…Background and Importance Immune checkpoint inhibitors (ICI) have become a standard treatment in multiple malignancies…
DAPTaspiriniP2Y12chronic kidney diseaseacute myocardial infarctionatrial fibrillationdiabetes mellitustertiary hospitalNon-ST-segment Elevation Myocardial InfarctionST-segment elevation myocardial infarction+5 more
…in discharge treatment between men and women were observed (eg, DAPT and anticoagulation), these were not statistically significant.…
Therapeutic drug monitoringlinezolidamiodaroneclarithromycinamlodipinesevere infectionslevothyroxineRifampicinphenobarbital
…acokinetic variability may compromise both efficacy and safety. Therapeutic drug monitoring (TDM) can optimise dosing and reduce the risk of adverse effect…
CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more
…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…
corticosteroid therapyipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinoma
…diated origin of hepatic and neurological alterations optimised corticosteroid therapy and improved patient safety.Material and Methods Ipilimumab/niv…